Fortrea Holdings: The Turnaround Is Showing Up In Earnings Before Revenue

Manimala Misra 40 Followers Follow Summary Fortrea Holdings Inc. is rated Buy at ~$18.86, driven by an earnings turnaround from aggressive cost reductions, not revenue growth. Adjusted EBITDA rose ~24% in H1 despite a ~3.4% revenue decline, as direct costs and SG&A fell faster than sales. Net new business awards increased ~19% YoY, with a trailing-12-month book-to-bill ratio of 1.12x, but revenue conversion remains uncertain. FTRE’s valuation is attractive on EV/Sales but less so on earnings; sustained earnings and cash flow improvement are critical for further upside. Monty Rakusen/DigitalVision via Getty Images Investment Thesis In Q2 2026 , reports showed that revenue declined to ~$678.2 million, or by ~4.5%, from the previous year. During the same period, adjusted EBITDA increased ~6.9% to ~$58.7 million, while the margin expanded ~93 bps to ~8.7%. At the same time, adjusted EPS rose by ~21.1%. In H1, the This article was written by Manimala Misra 40 Followers Follow Apart from my academic training in Biology and Chemistry, I hold a Ph.D. in Environmental Science with a specialization in Bio-Medical Waste Management. My areas of research and analysis include clean technologies, renewable energy, pollution control systems, and environmental compliance solutions. I follow companies operating in these sectors using a research-driven approach that integrates regulatory trends, sustainability metrics, and scientific evaluation to assess long-term growth opportunities, risks, and value potential. By actively tracking and analyzing companies engaged in environmental management, renewable energy, and green technologies, my work aims to blend scientific depth with market analysis to provide practical insights that help investors understand financial outcomes and emerging opportunities. At a personal level, I also provide free stock market consultation to a select group of friends, relatives, and former colleagues. I am associated with Seeking Alpha analyst Eudaemon Research. Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.